Search Results

Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis.

• Authors : Dompreh A; Department of Microbiology, Komfo Anokye Teaching Hospital, Kumasi, Ghana.; Tang X

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*pharmacokinetics ; Arylamine N-Acetyltransferase/Arylamine N-Acetyltransferase/Arylamine N-Acetyltransferase/*genetics ; Carboxylesterase/Carboxylesterase/Carboxylesterase/*genetics

• Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2018 Feb 23; Vol. 62 (3). Date of Electronic Publication: 2018 Feb 23 (Print Publication: 2018).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS.

• Authors : Egelund EF; Isaza R; Alsultan A

Subjects: Elephants*/Elephants*/Elephants*/blood; Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*pharmacokinetics ; Isoniazid/Isoniazid/Isoniazid/*pharmacokinetics

• Source: Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians [J Zoo Wildl Med] 2016 Sep; Vol. 47 (3), pp. 868-871.Publisher: American Association Of Zoo Veterinarians Country of Publication: United States NLM ID: 8915208 Publication Model: Print Cited Medium: Print

Record details

Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.

• Authors : Denti, Paolo; Wasmann, Roeland E; Rie, Annelies van

Subjects: DRUG therapy for tuberculosis; HIV-positive persons; BODY weightMALAWI; SOUTH Africa

• Source: Clinical Infectious Diseases; Jul2022, Vol. 75 Issue 1, p141-151, 11p

Record details

Four months of rifampicin monotherapy for latent tuberculosis infection in children.

• Authors : Chi Eun Oh; Menzies, Dick

Subjects: LATENT tuberculosis; RIFAMPIN; PATIENT compliance

• Source: Clinical & Experimental Pediatrics; May2022, Vol. 65 Issue 5, p214-221, 8p

Record details

A Rapid Pharmacogenomic Assay to Detect Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment.

• Authors : Verma, Renu; Patil, Sunita; Nan Zhang

Subjects: ANTITUBERCULAR agents; ACETYLTRANSFERASES; TUBERCULOSIS

• Source: American Journal of Respiratory & Critical Care Medicine; 12/1/2021, Vol. 204 Issue 11, p1317-1326, 10p

Record details

Drug exposure of first‐line anti‐tuberculosis drugs in China: A prospective pharmacological cohort study.

• Authors : Gao, Yazhou; Davies Forsman, Lina; Ren, Weihua

Subjects: ANTITUBERCULAR agents; ISONIAZID; RIFAMPINCHINA

• Source: British Journal of Clinical Pharmacology; Mar2021, Vol. 87 Issue 3, p1347-1358, 12p

Record details

Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.

• Authors : Justine, Museveni; Yeconia, Anita; Nicodemu, Ingi

Subjects: DRUG therapy for tuberculosis; ANTITUBERCULAR agents; HEALTH status indicatorsTANZANIAWORLD Health Organization

• Source: Journal of the Pediatric Infectious Diseases Society; Mar2020, Vol. 9 Issue 1, p14-20, 7p

Record details

Pharmacokinetics of First-Line Anti-Tubercular Drugs.

• Authors : Mukherjee, Aparna; Lodha, Rakesh; Kabra, S. K.

• Source: Indian Journal of Pediatrics; May2019, Vol. 86 Issue 5, p468-478, 11p

Record details

Agricola

Record details

A Critical Review of the Current Evidence for Measuring Drug Concentrations of First-Line Agents Used to Treat Tuberculosis in Children.

• Authors : Wilby, Kyle; Shabana, Sara; Ensom, Mary

Subjects: TUBERCULOSIS in children; DRUG dosage; RIFAMPIN

• Source: Clinical Pharmacokinetics; Jan2016, Vol. 55 Issue 1, p17-31, 15p, 2 Charts

Record details